Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 2000 Jul;46:1469–1477.

Practical management of hair loss.

J Shapiro 1, M Wiseman 1, H Lui 1
PMCID: PMC2144852  PMID: 10925761

Abstract

OBJECTIVE: To describe an organized diagnostic approach for both nonscarring and scarring alopecias to help family physicians establish an accurate in-office diagnosis. To explain when ancillary laboratory workup is necessary to confirm the diagnosis. QUALITY OF EVIDENCE: Current diagnostic and therapeutic interventions for hair loss are based on randomized controlled studies, uncontrolled studies, and case series. MEDLINE was searched from January 1966 to December 1998 with the MeSH words alopecia, hair, and alopecia areata. Articles were selected on the basis of experimental design, with priority given to the most current large multicentre controlled studies. Overall global evidence for therapeutic intervention for hair loss is quite strong. MAIN MESSAGE: The most common forms of nonscarring alopecias are androgenic alopecia, telogen effluvium, and alopecia areata. Other disorders include trichotillomania, traction alopecia, tinea capitis, and hair shaft abnormalities. Scarring alopecia is caused by trauma, infections, discoid lupus erythematosus, or lichen planus. Key to establishing an accurate diagnosis is a detailed history, including medication use, systemic illnesses, endocrine dysfunction, hair-care practices, and family history. All hair-bearing sites should be examined. A 4-mm punch biopsy of the scalp is useful, particularly to diagnose scarring alopecias. Once a diagnosis has been established, specific therapy can be initiated. CONCLUSIONS: Diagnosis and management of hair loss is an interesting challenge for family physicians. An organized approach to recognizing characteristic differential features of hair loss disorders is key to diagnosis and management.

Full text

PDF
1469

Images in this article

1471Figure 1
on p.1471
1472Figure 2
on p.1472
1475Figure 5
on p.1475
1475Figure 6
on p.1475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baudraz-Rosselet F., Monod M., Jaccoud S., Frenk E. Efficacy of terbinafine treatment of tinea capitis in children varies according to the dermatophyte species. Br J Dermatol. 1996 Dec;135(6):1011–1012. doi: 10.1046/j.1365-2133.1996.d01-1117.x. [DOI] [PubMed] [Google Scholar]
  2. Burke B. M., Cunliffe W. J. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia. Br J Dermatol. 1985 Jan;112(1):124–125. doi: 10.1111/j.1365-2133.1985.tb02305.x. [DOI] [PubMed] [Google Scholar]
  3. DeVillez R. L., Jacobs J. P., Szpunar C. A., Warner M. L. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch Dermatol. 1994 Mar;130(3):303–307. [PubMed] [Google Scholar]
  4. Legendre R., Esola-Macre J. Itraconazole in the treatment of tinea capitis. J Am Acad Dermatol. 1990 Sep;23(3 Pt 2):559–560. doi: 10.1016/0190-9622(90)70254-f. [DOI] [PubMed] [Google Scholar]
  5. Leyden J. L., Kligman A. M. Treatment of alopecia areata with steroid solution. Arch Dermatol. 1972 Dec;106(6):924–924. [PubMed] [Google Scholar]
  6. Montes L. F. Topical halcinonide in alopecia areata and in alopecia totalis. J Cutan Pathol. 1977;4(2):47–50. doi: 10.1111/j.1600-0560.1977.tb00889.x. [DOI] [PubMed] [Google Scholar]
  7. Norwood O. T. Male pattern baldness: classification and incidence. South Med J. 1975 Nov;68(11):1359–1365. doi: 10.1097/00007611-197511000-00009. [DOI] [PubMed] [Google Scholar]
  8. Olsen E. A., Weiner M. S., Amara I. A., DeLong E. R. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol. 1990 Apr;22(4):643–646. doi: 10.1016/0190-9622(90)70089-z. [DOI] [PubMed] [Google Scholar]
  9. Price V. H. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol. 1987 Mar;16(3 Pt 2):730–736. doi: 10.1016/s0190-9622(87)70095-4. [DOI] [PubMed] [Google Scholar]
  10. Shapiro J., Price V. H. Hair regrowth. Therapeutic agents. Dermatol Clin. 1998 Apr;16(2):341–356. doi: 10.1016/s0733-8635(05)70017-6. [DOI] [PubMed] [Google Scholar]
  11. Shapiro J. Topical immunotherapy in the treatment of chronic severe alopecia areata. Dermatol Clin. 1993 Jul;11(3):611–617. [PubMed] [Google Scholar]
  12. Swedo S. E., Leonard H. L., Rapoport J. L., Lenane M. C., Goldberger E. L., Cheslow D. L. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling) N Engl J Med. 1989 Aug 24;321(8):497–501. doi: 10.1056/NEJM198908243210803. [DOI] [PubMed] [Google Scholar]
  13. Whiting D. A. Chronic telogen effluvium. Dermatol Clin. 1996 Oct;14(4):723–731. doi: 10.1016/s0733-8635(05)70398-3. [DOI] [PubMed] [Google Scholar]
  14. Winter R. J., Kern F., Blizzard R. M. Prednisone therapy for alopecia areata. A follow-up report. Arch Dermatol. 1976 Nov;112(11):1549–1552. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES